These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39019014)

  • 1. Patient-derived tumor organoids to model drug response in gastric cancer.
    Vistoso Monreal A; Zhao H; Sedghizadeh PP; Lin DC
    Cell Rep Med; 2024 Jul; 5(7):101650. PubMed ID: 39019014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Organoid-Based Preclinical Model of Human Gastric Cancer.
    Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer.
    Zhao Y; Li S; Zhu L; Huang M; Xie Y; Song X; Chen Z; Lau HC; Sung JJ; Xu L; Yu J; Li X
    Cell Rep Med; 2024 Jul; 5(7):101627. PubMed ID: 38964315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
    Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
    Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening.
    Yan HHN; Siu HC; Law S; Ho SL; Yue SSK; Tsui WY; Chan D; Chan AS; Ma S; Lam KO; Bartfeld S; Man AHY; Lee BCH; Chan ASY; Wong JWH; Cheng PSW; Chan AKW; Zhang J; Shi J; Fan X; Kwong DLW; Mak TW; Yuen ST; Clevers H; Leung SY
    Cell Stem Cell; 2018 Dec; 23(6):882-897.e11. PubMed ID: 30344100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.
    Dijkstra KK; van den Berg JG; Weeber F; van de Haar J; Velds A; Kaing S; Peters DDGC; Eskens FALM; de Groot DA; Tesselaar MET; Voest EE
    Front Endocrinol (Lausanne); 2021; 12():627819. PubMed ID: 33776923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
    Li J; Xu H; Zhang L; Song L; Feng D; Peng X; Wu M; Zou Y; Wang B; Zhan L; Hua G; Zhan X
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2637-2647. PubMed ID: 31598791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine.
    Yang R; Qi Y; Kwan W; Du Y; Yan R; Zang L; Yao X; Li C; Zhu Z; Zhang X; Gao H; Cheong IH; Kozlakidis Z; Yu Y
    J Transl Med; 2024 Aug; 22(1):754. PubMed ID: 39135062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.
    Hao M; Cao Z; Wang Z; Xin J; Kong B; Xu J; Zhang L; Chen P
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3515-3525. PubMed ID: 35696669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenograft and organoid models in developing precision medicine for gastric cancer (Review).
    Xu J; Yu B; Wang F; Yang J
    Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38390969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human gastric cancer modelling using organoids.
    Seidlitz T; Merker SR; Rothe A; Zakrzewski F; von Neubeck C; Grützmann K; Sommer U; Schweitzer C; Schölch S; Uhlemann H; Gaebler AM; Werner K; Krause M; Baretton GB; Welsch T; Koo BK; Aust DE; Klink B; Weitz J; Stange DE
    Gut; 2019 Feb; 68(2):207-217. PubMed ID: 29703791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
    Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
    Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
    Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
    J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer patient-derived organoids model for the therapeutic drug screening.
    Xu J; Gong J; Li M; Kang Y; Ma J; Wang X; Liang X; Qi X; Yu B; Yang J
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130566. PubMed ID: 38244703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoids as research models for hepatocellular carcinoma.
    Yu JH; Ma S
    Exp Cell Res; 2022 Feb; 411(1):112987. PubMed ID: 34942189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDX-derived organoids model in vivo drug response and secrete biomarkers.
    Huang L; Bockorny B; Paul I; Akshinthala D; Frappart PO; Gandarilla O; Bose A; Sanchez-Gonzalez V; Rouse EE; Lehoux SD; Pandell N; Lim CM; Clohessy JG; Grossman J; Gonzalez R; Del Pino SP; Daaboul G; Sawhney MS; Freedman SD; Kleger A; Cummings RD; Emili A; Muthuswamy LB; Hidalgo M; Muthuswamy SK
    JCI Insight; 2020 Nov; 5(21):. PubMed ID: 32990680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.